

The Long Run with Luke Timmerman
Timmerman Report
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Mentioned books

Dec 11, 2018 • 1h 13min
Ep33: Krishna Yeshwant
Krishna Yeshwant of GV on life at the intersection of tech and biotech.

Nov 28, 2018 • 1h
Ep32: Ned David
Ned David on extending human healthspan.

Nov 14, 2018 • 59min
Ep31: Julie Sunderland
Julie Sunderland on VC investing at the nexus of tech and biotech.

Oct 31, 2018 • 1h
Ep30: Barbara Weber
Barbara Weber on synthetic lethal cancer drug discovery

Oct 16, 2018 • 1h 10min
Ep29: John Wilbanks
John Wilbanks on making it easy to share biological data.

Oct 2, 2018 • 1h 9min
Ep28: Sabah Oney
Sabah Oney on becoming a scientific business executive.

Sep 18, 2018 • 58min
Ep27: Amy Abernethy
Amy Abernethy on making EHRs useful for drug development.

Sep 5, 2018 • 55min
Ep26: Meg Tirrell
Meg Tirrell on covering biotech on TV.

Aug 21, 2018 • 1h 3min
Ep25: Thong Le
Thong Le on building startups to suit pharma needs.

Aug 7, 2018 • 59min
Ep24: Ankit Mahadevia
Ankit Mahadevia on the antibiotic opportunity